99.10
  Price1.59%   -1.60
(After Hours: 99.08 -0.0200 -0.02%)
Sep-27-21 09:45AM OPKO (OPK) BLA Review for Growth Hormone Deficiency Drug DelayedZacks Investment Research
08:01AM High Grade Gold Intersected in First Drill Program at Talga Talga Gold ProjectGlobeNewswire Inc.
Sep-18-21 09:13AM With Prothena Up Over 500% This Year, Is It Too Late to Get in?The Motley Fool
Sep-13-21 05:05AM 3 Out of 152 Closed-End Funds Yielding 7%+ To Consider (And They’re Cheap Now)Investing.com
Sep-09-21 11:07AM 2 Top Healthcare Stocks That Could Boost Your Portfolio in September (and Beyond)The Motley Fool
Sep-03-21 06:50AM This Could Mean Moderna and BioNTech Are Actually Dirt CheapThe Motley Fool
Aug-27-21 11:51AM Ascendis (ASND) Rallies on First FDA-Approved Drug SkytrofaZacks Investment Research
Aug-25-21 12:39PM 3 Big Drug/Biotech Outperformers Worth Keeping an Eye On (Revised)Zacks Investment Research
Aug-20-21 02:34AM House Committee Questions Eli Lilly, Sanofi, Novo Nordisk On 'Unacceptably High' Insulin PricesBenzinga
07:45AM The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine DataBenzinga
Aug-19-21 07:37AM The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With MerckBenzinga
Aug-18-21 09:24AM 3 Big Drug/Biotech Outperformers Worth Keeping an Eye OnZacks Investment Research
07:37AM The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKlineBenzinga
Aug-17-21 08:28AM The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology BusinessBenzinga
06:35AM 3 Low-Risk Stocks for Conservative InvestorsThe Motley Fool
Aug-16-21 03:56AM Walmart preview: U.S. sales growth at Walmart could outdo AmazonMarketWatch
10:31AM Walmart preview: U.S. sales growth at Walmart could outdo AmazonMarketWatch
Aug-16-21 09:10AM Why This 1 Growth Stock Could Be a Great Addition to Your PortfolioZacks Investment Research
07:43AM Walmart preview: U.S. sales growth at Walmart could outdo AmazonMarketWatch
Aug-14-21 12:14PM Walmart preview: U.S. sales growth at Walmart could outdo AmazonMarketWatch
09:21AM Walmart preview: U.S. sales growth at Walmart could outdo AmazonMarketWatch
Aug-13-21 11:40AM Here is Why Prothena (PRTA) is Up More Than 155% in Three MonthsZacks Investment Research
10:36AM Walmart preview: U.S. sales growth at Walmart could outdo AmazonMarketWatch
Aug-12-21 03:02AM Walmart preview: U.S. sales growth at Walmart could outdo AmazonMarketWatch
01:24AM Top Research Reports for Berkshire Hathaway, Cisco & Novo NordiskZacks Investment Research
Aug-12-21 11:38AM Walmart preview: U.S. sales growth at Walmart could outdo AmazonMarketWatch
Aug-07-21 10:02AM Here Are the Winners of Cowen's Big Pharma R&D ShowdownThe Motley Fool
Aug-06-21 12:41PM Prothena (PRTA) Q2 Earnings Top Estimates, Pipeline in FocusZacks Investment Research
09:30AM Pharma Stock Roundup: LLY, NVO, BAYRY Q2 Earnings, SNY's TBIO Buyout, FDA UpdatesZacks Investment Research
Aug-06-21 09:09AM Novo to Present at Upcoming WebinarsGlobeNewswire Inc.
07:42AM The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPOBenzinga
Aug-05-21 01:12AM Novo Nordisk's (NVO) Q2 Earnings and Sales Beat EstimatesZacks Investment Research
08:04AM The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEOBenzinga
Aug-04-21 12:43PM Novo Nordisk Shares Are Trading Higher As GLP-1 Treatments Boost Q2 Topline, Bottom-lineBenzinga
07:52AM The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On EarningsBenzinga
Aug-03-21 07:55AM The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics BusinessBenzinga
Jul-30-21 01:18AM Intercept's (ICPT) Q2 Loss Narrower Than Expected, Sales BeatZacks Investment Research
01:57AM Tracking Ken Fisher's Fisher Asset Management Portfolio - Q2 2021 UpdateSeeking Alpha
Jul-24-21 09:31AM Why Is Novo Nordisk Buying a Rare-Disease Candidate?The Motley Fool
Jul-23-21 07:45AM The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOsBenzinga
Jul-16-21 07:18AM Pharma Stock Roundup: NVO & LLY's Small Acquisitions, JNJ's Sunscreens RecallZacks Investment Research
Jul-14-21 03:21AM Biotech Stock Roundup: BIIB & PRTA Provide Updates, CLDX Up on Positive Data & MoreZacks Investment Research
Jul-13-21 12:22PM Prothena (PRTA) to Sell ATTR Amyloidosis Program to Novo NordiskZacks Investment Research
Jul-12-21 12:36PM Sigilon (SGTX) Down as FDA Places Hold on Hemophilia StudyZacks Investment Research
Jul-09-21 07:36AM The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPOBenzinga
Jul-08-21 07:45AM The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 TestBenzinga
Jul-05-21 01:08AM Gilead (GILD) Gains 19% YTD: What to Expect in The Second Half?Zacks Investment Research
11:40AM ABBV vs. NVO: Which Stock Is the Better Value Option?Zacks Investment Research
Jun-30-21 04:33AM Dow Jones Gains 187 Points on Walmart Healthcare Deal, Boeing Mega-OrderThe Motley Fool
Jun-29-21 09:03AM Walmart to launch lower-priced insulin offering savings of up to 75%MarketWatch
Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes Care and Obesity, and Biopharmaceuticals. The Diabetes Care and Obesity segment provides insulins, GLP-1 and related delivery systems, and oral anti-diabetic drugs and obesity. The Biopharmaceuticals segment offers products in the areas of haemophilia care, growth hormone therapy, and hormone replacement therapy. Novo Nordisk A/S has a research and licensing agreement with DUKE National University Singapore Medical School to develop stem cell-based treatments for chronic heart failure and age-related macular degeneration; and a strategic alliance with Evotec AG to discover and develop small molecule therapies to treat patients suffering from diabetes, obesity, and co-morbidities, as well as has a research collaboration with Kallyope Inc. The company markets and distributes its products through distributors and independent agents. Novo Nordisk A/S has a collaboration agreement with Embark Biotech ApS for the discovery of novel treatments for obesity and its associated metabolic pathologies. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.
Cap:    |  Volume (24h):